Identifies themes and clusters of stock movements
Market TodayThemes and Stocks SummaryThematic Stock SearchClick here for daily refresh schedule
WBA - Walgreens Boots Alliance Inc
$48.09
-0.06(-0.12%)9:00:01 PM 1/20/2021
Walgreens Boots Alliance, Inc. is an American holding company headquartered in Deerfield, Illinois, that owns Walgreens, Boots, and a number of pharmaceutical manufacturing, wholesale, and distribution companies. The company was formed on December 31, 2014, after Walgreens purchased the 55% stake in UK and Switzerland-based Alliance Boots that it did not already own. The total price of the acquisition was $4.9 billion in cash and 144.3 million common shares with fair value of $10.7 billion. Walgreens had previously purchased 45% of the company for $4.0 billion and 83.4 million common shares in August 2012 with an option to purchase the remaining shares within three years. Walgreens became a subsidiary of the newly created company after the transactions were completed. The company is organized into three divisions: Retail Pharmacy USA , Retail Pharmacy International , and Pharmaceutical Wholesale, incorporating Alliance Healthcare. The new holding company began trading on the NASDAQ on December 31, 2014.
Stock Chart

Summary:

  • RSI is at a high level of 71. A high level of RSI indicates the stock is overbought.
  • MACD is crossing MACD signal line at 0.5. MACD crossing signal line is bullish signal.

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Related Topics
leak data
Peers

Stock news

    01/20/2021WBA
    8 Quality Dividend Stocks for Durable Growth and Income

    From "Dividend Aristocrats" to special situations, Ben Reynolds -- along with his co-editors Bob Ciura and Nikolaos Sismanis -- provides in-depth research on high-quality stocks through its four top-ranked newsletters. Scale is a critical competitive advantage in the industry. The company's durable competitive advantage -- and shareholder friendliness -- is on display with its long dividend history.

    01/20/2021WBA
    Is WBA Stock A Buy After Earnings Report While Vaccines Roll Out?

    WBA stock is trying to navigate a choppy retail climate amid the coronavirus pandemic. Is Walgreens stock a buy?

    01/19/2021WBA
    No7 Laboratories Resurfacing Peel 15% Glycolic Acid Officially Launches in U.S. Market

    No7, a leader in skincare innovation since 1935, announces the launch of the newest addition to their Laboratories collection, No7 Laboratories Resurfacing Peel 15% Glycolic Acid. With chemical peels being one of the top reasons consumers in the U.S. visit a dermatologist, the product serves as a timely alternative for those seeking to replace in-office dermatological treatments at home. The product is a new addition to the No7 Laboratories collection and strengthens No7's commitment to providin...

    01/16/2021WBA
    Benzinga's Weekly Bulls And Bears: AMD, Marathon, Tesla, Uber, Walgreens And More

    * Benzinga has examined the prospects for many investor favorite stocks over the past week. * The week's bullish calls included the electric vehicle leader and a recovering retailer. * A ride-sharing company and a semiconductor maker were among the bearish calls.As the fourth-quarter earnings reporting season got underway last week, the major U.S. indexes lost a little ground. The Dow Jones industrial average concluded the week down about 1%, and the S&P 500 and Nasdaq retreated a little more...

    01/16/2021WBA
    Walgreens Statement in Support of President-Elect Biden’s COVID-19 Update

    Following President-elect Joe Biden’s COVID-19 Update, Walgreens issued the following statement from John Standley, Walgreens president.

    01/15/2021WBA
    FOCUS-Some U.S. nursing home residents face delays for COVID-19 vaccines despite extreme risk

    A former Arkansas health official is sounding alarms about the pace of coronavirus vaccines being administered to residents of long-term care facilities under a U.S. plan that puts major pharmacy chains CVS and Walgreens in charge of many of the shots. Fewer than 10% of doses allocated to those Arkansas seniors have been administered, according to the state health department. The two pharmacies are working with about 40% of the state's facilities.

    01/15/2021WBA
    West Virginia is vaccinating people faster than California — here’s why

    One key to unlocking the logjam of COVID-19 vaccines is in plain view but so far overlooked: the neighborhood retail pharmacy. As of Monday,  9 million people had received at least one dose of the Pfizer (PFE) or Moderna (MRNA) vaccines since they were approved in December. Pfizer’s vaccine must be stored at minus 70 degrees Celsius which complicates inoculation efforts that are not close to specialty freezers.

    01/14/2021WBA
    One Family Property Announces Acquisition Of Investment Property

    OFP Real Estate, LLC (a/k/a One Family Property) ("OFP") announced today that it closed on the acquisition of a net-leased investment tenanted by Walgreens Boots Alliance (NASDAQ: WBA) located in a Cleveland, Ohio metro market. The investment was acquired with a long-term lease in place, providing stable, strong, and predictable returns. This transaction marked the companies first 2021 acquisition.

    01/13/2021WBA
    N.J. Opens Vaccines to 65 and Over, Those With Health Issues

    (Bloomberg) -- New Jersey will expand Covid-19 vaccinations to people 65 years old and over and those ages 16 to 64 who have “health challenges,” Governor Phil Murphy said. The new group includes smokers, those who are obese, and people being treated for cancer, diabetes and kidney and cardiac disorders.New Jersey set a six-month goal of immunizing 4.7 million people, about 70% of the population. The new eligibility means that at least 2 million people will have access to one of two Covid-19 vac...